In an interview on CNBC's Mad Money, Chipotle CEO Brian Niccol said: We've put together a new team... The core of our business is great ingredients... The brand stands for something special... We have a second line that handles digital orders and that is a huge advantage for us... The second line of digital/delivery doesn't interfere with the restaurant experience... We are investing in the young farmer... We don't compromise on food freshness.

Black Hills announced that its South Dakota Electric and Wyoming Electric utilities, doing business as Black Hills Energy, received approval from the South Dakota Public Utilities Commission to increase the offering under its Renewable Ready program by 12.5 megawatts and a determination from the Wyoming Public Service Commission that the proposed increase of the Corriedale Wind Energy Project to 52.5 megawatts is within commission rules. With these actions, Black Hills Energy will install five additional wind turbines, increasing the wind project from 40 megawatts to 52.5 megawatts and the project cost from $57M to $79M.

Columbia Financial announced that it has expanded its stock repurchase program to acquire an additional 3,000,000 shares of the company's outstanding common stock in addition to the shares remaining under the repurchase program announced on June 11, 2019. Through September 30, 2019, the company has repurchased approximately 2,742,000 shares for approximately $42.1M under its previously announced stock repurchase program. Repurchases under the stock repurchase program may be made in open market transactions or privately negotiated transactions, and pursuant to a trading plan that the company intends to adopt in accordance with Rule 10b5-1 of the Securities and Exchange Commission.

Biohaven Pharmaceutical announced that the USPTO issued a patent relating to troriluzole. Biohaven's patent is directed to the composition of matter of troriluzole, a novel prodrug of a glutamate modulator, as well as other compounds, pharmaceutical compositions and methods of treating diseases including, for example, neurological disorders such as Alzheimer's disease, generalized anxiety disorder, social anxiety disorder, and depression. The U.S. patent is not expected to expire before February 26, 2036.

The Hanover Insurance Group announced it has entered into an accelerated share repurchase agreement to buy back $150M of its common stock.With the $150 million ASR agreement and the $100 million, the company has completed the deployment of $850 million of capital generated through the sale of Chaucer, its Lloyd's business, at the end of 2018.